Impact of CD39 and Purinergic Signalling on the Growth and Metastasis of Colorectal Cancer

Purinergic Signalling - Netherlands
doi 10.1007/s11302-011-9228-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Overexpression of DHX32 Contributes to the Growth and Metastasis of Colorectal Cancer

Scientific Reports
Multidisciplinary
2015English

Oestrogen Receptor Signalling and Colorectal Cancer

International Journal of Colorectal Disease
Gastroenterology
2009English

RUNX1 Promotes Tumour Metastasis by Activating the WNT/Β-Catenin Signalling Pathway and EMT in Colorectal Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

MYH9 Promotes Growth and Metastasis via Activation of MAPK/AKT Signaling in Colorectal Cancer

Journal of Cancer
Oncology
2019English

Notch Signalling in Cancer Progression and Bone Metastasis

British Journal of Cancer
Cancer ResearchOncology
2011English

Purinergic Signalling: Therapeutic Developments

Frontiers in Pharmacology
Pharmacology
2017English

Short- And Long-Term (Trophic) Purinergic Signalling

Philosophical Transactions of the Royal Society B: Biological Sciences
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2016English

Purinergic Signalling in the Pancreas in Health and Disease

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2012English

Growth Patterns of Colorectal Cancer Liver Metastases and Their Impact on Prognosis: A Systematic Review

BMJ Open Gastroenterology
Gastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy